Ohio State University, Columbus

- Experts are recommending that patients with sickle cell disease avoid possibility of infection from COVID-19 as much as possible due to increased risk for severe effects
- Additionally, patients with sickle cell are advised to manage their sickle cell the best they possibly can at home before coming to a hospital
- When patients receive blood transfusions to mitigate stroke risk, it is suggested that patients are slowly put onto a hydroxyurea treatment regimen as there is a shortage of blood during the pandemic
- This paper also provides a more in-depth procedure of what steps should physicians and patients alike should take for managing and triaging sickle cell during the COVID-19 era shown in Figure 1


New Communication and Treatment Strategies for Patients with Sickle Cell Disease and COVID-19

Menapace, L. A., & Thein, S. L. (2020). COVID-19 and sickle cell disease. Haematologica, 105(11), 2501–2504. https://doi.org/10.3324/haematol.2020.255398

URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604559/

Learn Before

Related